3.63
price down icon11.25%   -0.46
 
loading

Pepgen Inc Aktie (PEPG) Neueste Nachrichten

pulisher
Dec 20, 2024

Wedbush Comments on PepGen’s FY2028 Earnings (NASDAQ:PEPG) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Fmr LLC Sells 327,160 Shares of PepGen Inc. (NASDAQ:PEPG) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Wedbush Has Bullish Forecast for PepGen FY2028 Earnings - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

FDA Pauses PepGen’s DMD Drug Trial in the US - AJMC.com Managed Markets Network

Dec 19, 2024
pulisher
Dec 17, 2024

PepGen stock craters 35% on FDA clinical hold - MSN

Dec 17, 2024
pulisher
Dec 17, 2024

PepGen (NASDAQ:PEPG) Downgraded by Bank of America to Underperform - Defense World

Dec 17, 2024
pulisher
Dec 16, 2024

FDA halts PepGen's DMD trial; ongoing study continues By Investing.com - Investing.com Australia

Dec 16, 2024
pulisher
Dec 16, 2024

PepGen stock touches 52-week low at $2.9 amid market challenges - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

FDA halts PepGen's DMD trial; ongoing study continues - Investing.com India

Dec 16, 2024
pulisher
Dec 16, 2024

PepGen shares downgraded to Underperform by BofA amid uncertainty over clinical hold - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

PepGen stock down 22% on FDA clinical hold (update) (PEPG:NASDAQ) - Seeking Alpha

Dec 16, 2024
pulisher
Dec 16, 2024

PepGen stock touches 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 16, 2024

Novo builds up manufacturing; Pepgen Duchenne trial put on hold - BioPharma Dive

Dec 16, 2024
pulisher
Dec 16, 2024

Déjà Vu for PepGen as FDA Places Hold on DMD Drug - BioSpace

Dec 16, 2024
pulisher
Dec 16, 2024

PepGen Shares Tumble Premarket as FDA Puts Study on Clinical Hold - MarketWatch

Dec 16, 2024
pulisher
Dec 16, 2024

PepGen Announces Clinical Hold in the U.S. on IND Application to Initiate CONNECT2-EDO51 Phase 2 Study of PGN-EDO51 for Duchenne Muscular Dystrophy - Business Wire

Dec 16, 2024
pulisher
Dec 11, 2024

When (PEPG) Moves Investors should Listen - Stock Traders Daily

Dec 11, 2024
pulisher
Dec 10, 2024

Frazier Life Sciences Management L.P. Sells 800,094 Shares of PepGen Inc. (NASDAQ:PEPG) - MarketBeat

Dec 10, 2024
pulisher
Dec 08, 2024

PepGen Inc. (NASDAQ:PEPG) Shares Bought by Janus Henderson Group PLC - MarketBeat

Dec 08, 2024
pulisher
Nov 29, 2024

PepGen Inc. (NASDAQ:PEPG) Shares Acquired by Suvretta Capital Management LLC - MarketBeat

Nov 29, 2024
pulisher
Nov 27, 2024

Myotonic Dystrophy Clinical Trial Pipeline Boom as Over 20 Companies Leading the Charge in Research and Development | DelveInsight - Yahoo Finance

Nov 27, 2024
pulisher
Nov 21, 2024

PepGen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Senior Vice President, Clinical Development - Business Wire

Nov 21, 2024
pulisher
Nov 21, 2024

Two new option listings and one option delisting on November 21st - TipRanks

Nov 21, 2024
pulisher
Nov 21, 2024

PepGen Grants 95,000 Share Options to New Clinical Development SVP | PEPG Stock News - StockTitan

Nov 21, 2024
pulisher
Nov 19, 2024

Here's Why We're Watching PepGen's (NASDAQ:PEPG) Cash Burn Situation - Simply Wall St

Nov 19, 2024
pulisher
Nov 18, 2024

BofA lowers PepGen stock target as trial delays and competition weigh on outlook - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Bank of America Cuts PepGen (NASDAQ:PEPG) Price Target to $6.00 - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

PepGen price target lowered to $6 from $10 at BofA - TipRanks

Nov 18, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition of PepGen Inc Shares - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Leerink Partnrs Issues Positive Forecast for PepGen Earnings - MarketBeat

Nov 13, 2024
pulisher
Nov 08, 2024

PepGen (NASDAQ:PEPG) Price Target Cut to $12.00 by Analysts at Wedbush - MarketBeat

Nov 08, 2024
pulisher
Nov 08, 2024

PepGen (NASDAQ:PEPG) Earns "Buy" Rating from HC Wainwright - MarketBeat

Nov 08, 2024
pulisher
Nov 07, 2024

PepGen Inc (PEPG) Quarterly 10-Q Report - Quartz

Nov 07, 2024
pulisher
Nov 07, 2024

PepGen reports Q3 EPS (66c), consensus (87c) - TipRanks

Nov 07, 2024
pulisher
Nov 07, 2024

PepGen Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights - BioSpace

Nov 07, 2024
pulisher
Nov 07, 2024

PepGen Reports Improved Q3 Loss, $138.9M Cash Runway Extends to 2026 - StockTitan

Nov 07, 2024
pulisher
Nov 06, 2024

We're Keeping An Eye On PepGen's (NASDAQ:PEPG) Cash Burn Rate - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

Objective long/short (PEPG) Report - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 04, 2024

PepGen to Participate in Upcoming Investor Conferences - Business Wire

Nov 04, 2024
pulisher
Oct 26, 2024

(PEPG) Technical Data - Stock Traders Daily

Oct 26, 2024
pulisher
Oct 15, 2024

(PEPG) Proactive Strategies - Stock Traders Daily

Oct 15, 2024
pulisher
Oct 08, 2024

PepGen Announces Presentations at the 29th Annual Congress of the World Muscle Society - Business Wire

Oct 08, 2024
pulisher
Oct 01, 2024

Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher - Benzinga

Oct 01, 2024
pulisher
Sep 24, 2024

When the Price of (PEPG) Talks, People Listen - Stock Traders Daily

Sep 24, 2024
pulisher
Sep 20, 2024

PepGen Inc. Announces Christopher Ashton to Retire from Its Board of Directors, Effective September 30, 2024 - Marketscreener.com

Sep 20, 2024
pulisher
Sep 20, 2024

PepGen director Christopher Ashton to retire at month's end - Investing.com

Sep 20, 2024
pulisher
Sep 20, 2024

PepGen director Christopher Ashton to retire at month's end By Investing.com - Investing.com Australia

Sep 20, 2024
pulisher
Sep 19, 2024

PepGen Inc. Board Reshuffles as Ashton Plans Retirement - TipRanks

Sep 19, 2024
pulisher
Sep 19, 2024

PepGen Announces Christopher Ashton, PhD, to Retire from its Board of Directors - Business Wire

Sep 19, 2024
pulisher
Sep 17, 2024

Sofinnova Investments Inc. Has $8.96 Million Holdings in PepGen Inc. (NASDAQ:PEPG) - MarketBeat

Sep 17, 2024
pulisher
Sep 14, 2024

Investigation announced for Investors who lost money with - openPR

Sep 14, 2024
pulisher
Sep 13, 2024

Trend Tracker for (PEPG) - Stock Traders Daily

Sep 13, 2024
pulisher
Sep 05, 2024

PepGen Inc [NASDAQ: PEPG] Sees Decrease in Stock Value - Knox Daily

Sep 05, 2024
pulisher
Sep 05, 2024

PepGen (NASDAQ:PEPG) Trading Down 0.4% - MarketBeat

Sep 05, 2024
pulisher
Aug 28, 2024

(PEPG) Long Term Investment Analysis - Stock Traders Daily

Aug 28, 2024
pulisher
Aug 24, 2024

PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Vice President, Research & Development - Manchestertimes

Aug 24, 2024
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):